CSNK2A1 and neoplasm: In vivo tumor growth of KHOS/NP cells was also significantly decreased with the transfection of the SIRT6-S338A mutant compared with the overexpression of WT-CSNK2A1 or WT-CSNK2A1/WT-SIRT6 (Figure 8a–c).